IRIS UniCatt

Ferraccioli, Gianfranco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.315
EU - Europa 7.060
AS - Asia 2.878
SA - Sud America 308
AF - Africa 50
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 23
Totale 17.662
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.241
DE - Germania 1.860
CN - Cina 1.162
SE - Svezia 1.064
SG - Singapore 969
IT - Italia 864
PL - Polonia 734
UA - Ucraina 666
FR - Francia 636
IE - Irlanda 380
BR - Brasile 254
GB - Regno Unito 245
ID - Indonesia 230
FI - Finlandia 198
IN - India 172
RU - Federazione Russa 150
TR - Turchia 96
BE - Belgio 89
HK - Hong Kong 62
CA - Canada 53
JP - Giappone 38
IR - Iran 36
NL - Olanda 26
AU - Australia 23
CI - Costa d'Avorio 23
CH - Svizzera 17
VN - Vietnam 17
AT - Austria 16
AR - Argentina 15
ES - Italia 15
CL - Cile 14
MX - Messico 14
CZ - Repubblica Ceca 13
RO - Romania 13
EU - Europa 12
DK - Danimarca 10
IQ - Iraq 10
LT - Lituania 10
A2 - ???statistics.table.value.countryCode.A2??? 8
CO - Colombia 8
EC - Ecuador 8
LK - Sri Lanka 8
PK - Pakistan 8
ZA - Sudafrica 8
BD - Bangladesh 7
BG - Bulgaria 7
GR - Grecia 7
NO - Norvegia 7
EG - Egitto 6
IL - Israele 6
KR - Corea 6
LV - Lettonia 6
SA - Arabia Saudita 6
LA - Repubblica Popolare Democratica del Laos 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
PT - Portogallo 5
TW - Taiwan 5
EE - Estonia 4
JO - Giordania 4
MA - Marocco 4
UZ - Uzbekistan 4
AM - Armenia 3
AZ - Azerbaigian 3
HU - Ungheria 3
KG - Kirghizistan 3
PA - Panama 3
SI - Slovenia 3
VE - Venezuela 3
A1 - Anonimo 2
AE - Emirati Arabi Uniti 2
CR - Costa Rica 2
HR - Croazia 2
LU - Lussemburgo 2
MD - Moldavia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
SC - Seychelles 2
TH - Thailandia 2
TJ - Tagikistan 2
UY - Uruguay 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
DZ - Algeria 1
GE - Georgia 1
JM - Giamaica 1
KH - Cambogia 1
LB - Libano 1
MK - Macedonia 1
MY - Malesia 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 17.660
Salva come PNG Salva come JPEG
Città #
Chandler 1.287
Warsaw 602
Singapore 549
Ashburn 531
Ann Arbor 390
Jacksonville 388
Dearborn 371
Dublin 363
San Mateo 318
Wilmington 287
Fairfield 273
Nanjing 249
Woodbridge 238
Jakarta 228
Cattolica 178
Houston 178
Seattle 168
Boston 150
Lawrence 140
New York 132
Kraków 121
Beijing 111
Milan 107
Moscow 103
Redwood City 92
Bremen 91
Marseille 85
Cambridge 83
Munich 83
Brussels 82
Izmir 81
Nürnberg 81
Nanchang 76
Rome 73
Princeton 68
Hong Kong 62
Kunming 61
Norwalk 57
Boardman 55
Lancaster 54
Pune 52
Mountain View 50
Los Angeles 49
Helsinki 47
Guangzhou 46
Hebei 46
Chicago 44
Shenyang 43
University Park 37
Hangzhou 36
Redmond 35
Tianjin 35
Falls Church 31
Frankfurt am Main 31
Hefei 28
Jiaxing 27
Shanghai 27
Changsha 26
London 26
Detroit 24
Toronto 24
Zhengzhou 24
Fremont 23
Abidjan 22
Jinan 22
Leawood 21
The Dalles 21
Andover 20
Augusta 19
Paris 17
Busto Arsizio 15
Nuremberg 15
São Paulo 15
Düsseldorf 14
Fuzhou 13
Ningbo 13
San Diego 13
Simi Valley 13
Phoenix 12
Washington 12
Dong Ket 11
Kish 11
Lauterbourg 11
Tokyo 11
Ardabil 10
Ottawa 10
Santa Maria 10
Chengdu 9
Costa Mesa 9
Florence 9
Haikou 9
Perth 9
Portsmouth 9
Vienna 9
Belo Horizonte 8
Changchun 8
Clearwater 8
Dallas 8
Lanzhou 8
Torino 8
Totale 9.919
Salva come PNG Salva come JPEG
Nome #
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue 394
Modeling the ternary complex TCR-Vbeta/CollagenII(261-273)/HLA-DR4 associated with rheumatoid arthritis. 341
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 328
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 303
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 285
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 275
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 245
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 214
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 202
Impatto dell’inquinamento ambientale da benzene e PM10 sulla progressione clinica della sclerosi sistemica: un’analisi di correlazione. 193
Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment 180
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 178
MR imaging of atlantoaxial joint in early rheumatoid arthritis. 170
Allocare risorse nel settore di farmaci biologici: il caso di Etanercept per il trattamento dell’artrite reumatoide 164
Septic sacroiliitis: an uncommon septic arthritis 155
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression 150
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 150
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 147
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue. 145
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 144
Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. 143
Collagen-specific T cell repertoire in blood and synovial fluid varies with disease activity in Early Rheumatoid Arthritis. 141
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 141
Atlantoepistrophic magnetic resonance imaging involvement in early rheumatoid arthritis: an aggressive tight control therapy not fully arresting the disease 140
Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein 132
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 131
beta-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up 130
Modeling the Ternary Complex TCR-V beta/CollagenII(261-273)/HLA-DR4 Associated with Rheumatoid Arthritis 129
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 129
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor. 128
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 127
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections 125
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 124
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 124
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ. 122
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 122
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 120
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 118
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 117
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 116
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 116
Preliminary classification criteria for the cryoglobulinaemic vasculitis 116
ENVIRONMENTAL POLLUTION AND SYSTEMIC SCLEROSIS: A PILOT STUDY ON BENZENE AND PARTICULATE EXPOSURE AS RISK FACTORS FOR THE SYSTEMIC MANIFESTATIONS 113
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 113
An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus 113
New therapeutic effects of cilostazol in patients with ischemic disorders. 107
The potential role of Th17 in mediating the transition from acute to chronic autoimmune inflammation: rheumatoid arthritis as a model. 106
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 106
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 105
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 105
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 105
A paraneoplastic retroperitoneal fibrosis resistant to corticosteroids treated with tamoxifen. 104
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 101
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 100
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 99
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 98
Artrite reumatoide. Terapia 96
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 96
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 96
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 95
Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst 93
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 93
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 92
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 92
Environmental pollution and systemic sclerosis manifestations: a pilot study on benzene and particulate exposure 91
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 90
Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis 89
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 89
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 87
Selective Inhibitors of T Cell Receptor Recognition of Antigen–MHC Complexes for Rheumatoid Arthritis 87
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 87
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 86
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 86
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 84
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ. 84
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression 84
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus 81
Polimialgia reumatica ed arterite temporale di Horton 80
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 80
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 80
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 80
The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk 79
Immunosuppressive Therapy (Methotrexate or Cyclophosphamide) in Combination with Corticosteroids in the Treatment of Giant Cell Arteritis: Comparison with Corticosteroids Alone 78
Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: A post hoc analysis of a phase III trial 78
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 78
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 77
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 75
Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus 74
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 74
The human salivary proteome: a critical overview of the results obtained by different proteomic platforms 73
Validation of the classification criteria for cryoglobulinaemic vasculitis 73
CTLA-4 Ig as an effective treatment in a patient with type I diabetes mellitus and seropositive rheumatoid arthritis 73
New therapeutic effects of cilostazol in patients with ischemic disorders 73
Association between the response to B cell depletion therapy and the allele*2 of the HS1,2A enhancer in seropositive rheumatoid arthritis patients 72
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. 71
Position paper of Italian rheumatologists on the use of biosimilar drugs 71
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 71
Troponin in Stable Ischemic Heart Disease and Diabetes 69
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 69
Adiposity, joint and systemic inflammation: the additional risk of having a metabolic syndrome in rheumatoid arthritis 68
Totale 12.223
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.334
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.334
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020438 0 0 0 0 0 0 0 0 0 0 253 185
2020/20211.919 129 189 261 165 230 89 167 38 239 106 255 51
2021/20221.961 219 158 60 102 131 75 69 296 92 141 272 346
2022/20233.649 461 485 283 597 262 434 151 323 416 45 115 77
2023/20241.773 85 543 67 76 50 243 125 94 18 52 270 150
2024/20252.081 73 93 294 118 323 87 75 165 526 293 34 0
Totale 17.945